B6J.B6N-H2ajem1Cmnn/Orl

Status

Available to order

EMMA IDEM:13661
Citation informationRRID:IMSR_EM:13661 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6J.B6N-H2ajem1Cmnn/Orl
Alternative nameH2afjDel7 (B6JRj)
Strain typeEndonuclease-mediated
Allele/Transgene symbolH2ajem1Cmnn
Gene/Transgene symbolH2aj

Information from provider

ProviderCarl MANN
Provider affiliationGenome Biology, CEA/Saclay
Genetic informationTALEN-mediated 7-nucleotide deletion at the beginning of the H2aj (or H2afj) gene. The same targeted mutation (H2afj∆7) was back-crossed 6 times to either C57BL/6N (EM:13660) or C57BL/6J (EM:13661) as there are a few crucial differences between these 2 substrains. In particular, B6J carries an Nnt∆ mutation that makes the mice particularly susceptible to a high-fat diet and it is often used for such studies. The B6N substrain does not carry this mutation (but it has other mutations not found in the B6J substrain).
Phenotypic informationHomozygous:
Homozygous mutant is viable and fertile. Phenotypic characterization is ongoing. The mutant gains weight less quickly than the isogenic wild-type control and may have lower levels of expression of some inflammatory genes. The mutant may show some protection from deleterious phenotypes induced by hat fat diet (in the C57BL/6J background) and ageing.

Heterozygous:
Heterozygous mutant is viable and fertile. No further phenotypic characterization was done with the heterozygous mutant.
Breeding historyThe original heterozygous mutation was a TALEN-mediated 7-nucleotide deletion near the beginning of the H2afj gene in C57BL/6N (Charles River) created by Cyagen. It was backcrossed 6 times with C57BL/6JRj from Janvier Labs. The homozygous mutant is viable and fertile and the strain has been maintained as a homozygote.
References
  • Human skin aging is associated with increased expression of the histone variant H2A.J in the epidermis.;Rübe Claudia E, Bäumert Caroline, Schuler Nadine, Isermann Anna, Schmal Zoé, Glanemann Matthias, Mann Carl, Scherthan Harry, ;2021;NPJ aging and mechanisms of disease;7;7; 33795696
  • Histone variant H2A.J accumulates in senescent cells and promotes inflammatory gene expression.;Contrepois Kévin, Coudereau Clément, Benayoun Bérénice A, Schuler Nadine, Roux Pierre-François, Bischof Oliver, Courbeyrette Régis, Carvalho Cyril, Thuret Jean-Yves, Ma Zhihai, Derbois Céline, Nevers Marie-Claire, Volland Hervé, Redon Christophe E, Bonner William M, Deleuze Jean-François, Wiel Clotilde, Bernard David, Snyder Michael P, Rübe Claudia E, Olaso Robert, Fenaille François, Mann Carl, ;2017;Nature communications;8;14995; 28489069
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreCNRS-TAAM – Typing and Archiving of Animal Models, Orléans, France
Animals used for archivinghomozygous males

Literature references

  • Human skin aging is associated with increased expression of the histone variant H2A.J in the epidermis.;Rübe Claudia E, Bäumert Caroline, Schuler Nadine, Isermann Anna, Schmal Zoé, Glanemann Matthias, Mann Carl, Scherthan Harry, ;2021;NPJ aging and mechanisms of disease;7;7; 33795696
  • Histone variant H2A.J accumulates in senescent cells and promotes inflammatory gene expression.;Contrepois Kévin, Coudereau Clément, Benayoun Bérénice A, Schuler Nadine, Roux Pierre-François, Bischof Oliver, Courbeyrette Régis, Carvalho Cyril, Thuret Jean-Yves, Ma Zhihai, Derbois Céline, Nevers Marie-Claire, Volland Hervé, Redon Christophe E, Bonner William M, Deleuze Jean-François, Wiel Clotilde, Bernard David, Snyder Michael P, Rübe Claudia E, Olaso Robert, Fenaille François, Mann Carl, ;2017;Nature communications;8;14995; 28489069

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).